E3 PreliminaryPreliminaryPEM not requiredReview-NarrativePeer-reviewedReviewed
Gray matter volumes in patients with chronic fatigue syndrome.
Tang, Le-Wei, Zheng, Hui, Chen, Liang et al. · Evidence-based complementary and alternative medicine : eCAM · 2015 · DOI
Quick Summary
This review examines brain imaging studies that found smaller brain regions in people with ME/CFS. The researchers looked at how other conditions—like chronic pain, stress, sleep problems, and depression—might affect these brain changes and make it harder to understand what's really happening in ME/CFS. By separating out these overlapping factors, scientists hope to better understand the true brain mechanisms behind ME/CFS.
Why It Matters
Understanding whether brain structure changes are fundamental to ME/CFS or secondary to its associated conditions (pain, stress, inactivity) is crucial for developing targeted treatments and validating biomarkers. This critical examination helps researchers design better-controlled studies that can identify the true neurobiological basis of ME/CFS rather than artifacts of overlapping symptoms.
Observed Findings
- Multiple neuroimaging studies report reduced gray matter volumes in certain brain regions of ME/CFS patients
- Chronic pain, stress, psychiatric disorders, reduced physical activity, and insomnia each independently affect gray matter volume
- These confounding factors significantly overlap with ME/CFS symptoms, potentially biasing neuroimaging results
- Few existing studies adequately controlled for all major confounding variables when measuring brain structure changes
Inferred Conclusions
- Brain structure changes observed in ME/CFS may not be disease-specific but rather reflect the cumulative effect of pain, stress, reduced activity, and sleep disruption
- Future neuroimaging studies must carefully control for major confounding variables to identify pathology truly unique to ME/CFS
- Central nervous system mechanisms in ME/CFS remain uncertain without better methodological controls in research
Remaining Questions
- Which gray matter changes, if any, are primary features of ME/CFS versus secondary effects of comorbidities?
- How do brain structure changes correlate with disease severity and duration when confounders are properly controlled?
- What longitudinal brain imaging studies following newly diagnosed patients with careful covariate control might reveal about ME/CFS pathogenesis?
What This Study Does Not Prove
This review does not establish whether gray matter changes are a primary cause of ME/CFS or merely a consequence of living with the disease and its comorbidities. It does not prove specific brain regions are uniquely affected by ME/CFS, nor does it establish causation—only that association has been reported across multiple studies with varying controls for confounding factors.
Tags
Symptom:Cognitive DysfunctionUnrefreshing SleepPainFatigue
Biomarker:Neuroimaging
Method Flag:PEM Not DefinedWeak Case DefinitionExploratory Only
Metadata
- DOI
- 10.1155/2015/380615
- PMID
- 25792998
- Review status
- Editor reviewed
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 12 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.